Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Thalassemia Intermedia,”

111 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 111 results

Post-approval studies (Phase 4)UnknownNCT03392298
What this trial is testing

Study on the Mechanism of Colla Corri Asini in the Treatment of Thalassemia Patients With Pregnancy Anemia

Who this might be right for
ThalassemiaPregnancy
The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine 70
Not applicableStudy completedNCT03161899
What this trial is testing

Evaluation of Nutritional Status in Thalassemia Major Patients in Assiut Children Hospital

Who this might be right for
Thalassemia Major
Assiut University 246
Large-scale testing (Phase 3)Study completedNCT03851055
What this trial is testing

Zinc Supplementation in Patients With β-Thalassemia Major Complicated With Diabetes Mellitus

Who this might be right for
Beta-thalassemia Major Complicated With Diabetes
Ain Shams University 80
Large-scale testing (Phase 3)Study completedNCT00061750
What this trial is testing

Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions

Who this might be right for
Beta-Thalassemia
Novartis Pharmaceuticals 595
Very early researchActive Not RecruitingNCT06065189
What this trial is testing

Base-edited Autologous Hematopoietic Stem Cell Transplantation in Treating Patients With β-thalassemia Major

Who this might be right for
Beta-Thalassemia
Children's Hospital of Fudan University 5
Not applicableStudy completedNCT06468423
What this trial is testing

Comparison of Deferasirox and Desferoxamine in Patients of β-Thalassemia Major With Iron Overload

Who this might be right for
Pateints of β-thalassemia Major With Iron Overload
RESnTEC, Institute of Research 142
Not applicableLooking for participantsNCT06219239
What this trial is testing

Safety and Efficacy of the Lentiviral Vector in Gene Therapy of Beta-thalassemia Patients

Who this might be right for
Transfusion-dependent Beta-Thalassemia
Institute of Hematology & Blood Diseases Hospital, China 3
Not applicableUnknownNCT02067130
What this trial is testing

Utility of Fibroscan in Estimating Hepatic Iron Concentration

Who this might be right for
Hereditary Anemias
University of British Columbia 30
Testing effectiveness (Phase 2)Study completedNCT00069862
What this trial is testing

Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-Thalassemia

Who this might be right for
Beta-Thalassemia
Genzyme, a Sanofi Company 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT00061568
What this trial is testing

Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias

Who this might be right for
Congenital Hemolytic AnemiaSickle Cell Disease
National Heart, Lung, and Blood Institute (NHLBI) 130
Not applicableStudy completedNCT00005893
What this trial is testing

Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders

Who this might be right for
NeutropeniaSickle Cell AnemiaThalassemia Major+1 more
Fairview University Medical Center
Testing effectiveness (Phase 2)Study completedNCT00004412
What this trial is testing

Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers

Who this might be right for
Skin UlcersSickle Cell Anemia
Susan P. Perrine 23
Post-approval studies (Phase 4)UnknownNCT02984475
What this trial is testing

The Potential Hepatoprotective Effect of Metformin in Patients With Beta Thalassemia Major

Who this might be right for
Beta Thalassemia Major Anemia
Cairo University 60
Testing effectiveness (Phase 2)Looking for participantsNCT04008368
What this trial is testing

Repeat Peripheral Blood Stem Cell Transplantation for Patients With Sickle Cell Disease and Falling Donor Myeloid Chimerism Levels

Who this might be right for
Myeloid Chimerism
National Heart, Lung, and Blood Institute (NHLBI) 32
Testing effectiveness (Phase 2)Ended earlyNCT01363908
What this trial is testing

Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload

Who this might be right for
Transfusional Iron OverloadBeta-Thalassemia
Shire 30
Testing effectiveness (Phase 2)Ended earlyNCT04059406
What this trial is testing

Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx)

Who this might be right for
Beta Thalassemia Intermedia
Ionis Pharmaceuticals, Inc. 29
Post-approval studies (Phase 4)Study completedNCT00749515
What this trial is testing

Pilot Study for Patients With Poor Response to Deferasirox

Who this might be right for
Transfusion-dependent HemachromatosisThalassemia MajorSickle Cell Disease
Boston Children's Hospital 15
Not applicableActive Not RecruitingNCT04523376
What this trial is testing

Pilot Study PBSCT with TCRab Depletion for Hemoglobinopathies

Who this might be right for
Sickle Cell DiseaseThalassemia Major
Timothy Olson 9
Not applicableActive Not RecruitingNCT04691323
What this trial is testing

The Longitudinal Relationship of HU Adherence to HRQOL, Barriers to Adherence and Habit in SCD.

Who this might be right for
Sickle Cell DiseaseSickle B+ ThalassemiaSickle Beta Zero Thalassemia+1 more
Ann & Robert H Lurie Children's Hospital of Chicago 68
Post-approval studies (Phase 4)WithdrawnNCT01724138
What this trial is testing

An Open Label Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Efficacy of Deferasirox Administered to Chinese Patients With β-thalassemia Major Aged From 2 to Less Than 6 Years Old

Who this might be right for
β-thalassemia Major
Novartis Pharmaceuticals
Load More Results